Compare BLLN & POST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLLN | POST |
|---|---|---|
| Founded | 2016 | 1895 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 5.0B |
| IPO Year | 2025 | 2011 |
| Metric | BLLN | POST |
|---|---|---|
| Price | $104.82 | $75.38 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 7 |
| Target Price | ★ $126.71 | $124.50 |
| AVG Volume (30 Days) | 501.7K | ★ 842.5K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 103.40 | N/A |
| EPS | 0.48 | ★ 4.59 |
| Revenue | $305,112,000.00 | ★ $8,158,100,000.00 |
| Revenue This Year | $46.29 | $4.93 |
| Revenue Next Year | $30.14 | $0.47 |
| P/E Ratio | $220.69 | ★ $16.64 |
| Revenue Growth | ★ 99.97 | 2.97 |
| 52 Week Low | $61.96 | $75.40 |
| 52 Week High | $150.44 | $116.35 |
| Indicator | BLLN | POST |
|---|---|---|
| Relative Strength Index (RSI) | 53.45 | 32.74 |
| Support Level | $79.07 | N/A |
| Resistance Level | $108.50 | $102.43 |
| Average True Range (ATR) | 5.08 | 2.09 |
| MACD | 1.86 | -0.51 |
| Stochastic Oscillator | 64.44 | 0.00 |
BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.
Post Holdings Inc. is a consumer packaged goods holding company with products sold through grocery, club, and drug stores, mass merchandisers, foodservice, food ingredient, and eCommerce. It operates through four reportable segments: Post Consumer Brands, focused on North American ready-to-eat cereal and granola, pet food, and nut butters; Weetabix, focused on U.K. ready-to-eat cereal, muesli, and protein-based shakes; Foodservice, focused on egg and potato products; and Refrigerated Retail, focused on side dish, egg, cheese, and sausage products. Products are sold across channels, including retailers, wholesalers, convenience stores, pet supply retailers, drug store customers, military and national restaurant chains, with revenues largely generated in the U.S.